Plenary Session 1 HB-EGF is a Potential Growth Factor for Cardiomyocyte Metabolism. The Possibility for a Novel Therapeutic Target for Heart Failure.
Seiji Takashima
Figure
2. The heart of the HB-EGF transgenic mice is enlarged at 12
weeks compared to the wild-type mice.
